Peptide-Functionalized Nanoparticles-Encapsulated Cyclin-Dependent Kinases Inhibitor Seliciclib in Transferrin Receptor Overexpressed Cancer Cells

Seliciclib, a broad cyclin-dependent kinases (CDKs) inhibitor, exerts its potential role in cancer therapy. For taking advantage of overexpressive transferrin receptor (TfR) on most cancer cells, T7 peptide, a TfR targeting ligand, was selected as a targeting ligand to facilitate nanoparticles (NPs)...

Descripción completa

Detalles Bibliográficos
Autores principales: He, Guan Zhen, Lin, Wen Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003333/
https://www.ncbi.nlm.nih.gov/pubmed/33803751
http://dx.doi.org/10.3390/nano11030772

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8003333/
https://www.ncbi.nlm.nih.gov/pubmed/33803751
http://dx.doi.org/10.3390/nano11030772

Ejemplares similares